1 2 3 4 Embrace gratitude December 10, 2020 • 7:00 a.m. by UTMB Employee Wellness As of 1:15 p.m., Dec. 9, 2020: December 9, 2020 • 4:02 p.m. by COVID-19 Communications This update includes information on COVID-19 testing and patient data as of Dec. 9, 2020, a vaccine update, wellness tips and more. Check in with someone today December 9, 2020 • 7:00 a.m. by UTMB Employee Wellness Do something helpful December 8, 2020 • 7:00 a.m. by UTMB Employee Wellness A Message from the UTMB COVID-19 Vaccination Preparedness Task Force: Preparing for Vaccination of UTMB Health Care Workers December 7, 2020 • 2:16 p.m. by UTMB COVID-19 Vaccination Preparedness Task Force This message is intended for UTMB employees, who must be logged onto the UTMB network to access it. Thank you. Take an outdoors walk December 7, 2020 • 7:00 a.m. by UTMB Employee Wellness Feed yourself with healthy, good food December 6, 2020 • 7:00 a.m. by UTMB Employee Wellness Notice if you’re hard on yourself December 5, 2020 • 7:00 a.m. by UTMB Employee Wellness A Message from the UTMB COVID-19 Vaccination Preparedness Task Force: Vaccine web page and FAQs, COVID-19 survey and more December 4, 2020 • 2:22 p.m. by UTMB COVID-19 Vaccination Preparedness Task Force This message is intended for UTMB employees, who must be logged onto the UTMB network to access it. Thank you. Leave a positive message December 4, 2020 • 7:00 a.m. by UTMB Employee Wellness Give the gift of listening December 3, 2020 • 7:00 a.m. by UTMB Employee Wellness As of Noon, Dec. 2, 2020 December 2, 2020 • 5:07 p.m. by COVID-19 Communications This update includes information on COVID-19 testing and patient data as of Dec. 2, 2020, a PPE update, how frontline workers can access free mental health support, wellness tips and more. Availability of COVID-19 antibodies for treatment of non-hospitalized, high-risk patients December 2, 2020 • 2:48 p.m. by UTMB COVID-19 Clinical Task Force Two new antibody products, bamlanivimab and casirivimab/imdevimab, have recently been approved by the FDA for emergency use authorization to avoid hospitalization in patients who are at a higher risk for developing severe symptoms of COVID-19. Support a charity December 2, 2020 • 7:00 a.m. by UTMB Employee Wellness Encourage more kindness December 1, 2020 • 7:00 a.m. by UTMB Employee Wellness Today, listen carefully November 30, 2020 • 7:00 a.m. by UTMB Employee Wellness Today, give someone a genuine compliment November 29, 2020 • 7:00 a.m. by UTMB Employee Wellness Today, get physical November 28, 2020 • 7:00 a.m. by UTMB Employee Wellness Today, remember Viktor Frankl November 27, 2020 • 7:00 a.m. by UTMB Employee Wellness oday, remember we all struggle at times November 26, 2020 • 7:00 a.m. by UTMB Employee Wellness 1 2 3 4 5 6 7 8 9 10 »
As of 1:15 p.m., Dec. 9, 2020: December 9, 2020 • 4:02 p.m. by COVID-19 Communications This update includes information on COVID-19 testing and patient data as of Dec. 9, 2020, a vaccine update, wellness tips and more.
A Message from the UTMB COVID-19 Vaccination Preparedness Task Force: Preparing for Vaccination of UTMB Health Care Workers December 7, 2020 • 2:16 p.m. by UTMB COVID-19 Vaccination Preparedness Task Force This message is intended for UTMB employees, who must be logged onto the UTMB network to access it. Thank you.
A Message from the UTMB COVID-19 Vaccination Preparedness Task Force: Vaccine web page and FAQs, COVID-19 survey and more December 4, 2020 • 2:22 p.m. by UTMB COVID-19 Vaccination Preparedness Task Force This message is intended for UTMB employees, who must be logged onto the UTMB network to access it. Thank you.
As of Noon, Dec. 2, 2020 December 2, 2020 • 5:07 p.m. by COVID-19 Communications This update includes information on COVID-19 testing and patient data as of Dec. 2, 2020, a PPE update, how frontline workers can access free mental health support, wellness tips and more.
Availability of COVID-19 antibodies for treatment of non-hospitalized, high-risk patients December 2, 2020 • 2:48 p.m. by UTMB COVID-19 Clinical Task Force Two new antibody products, bamlanivimab and casirivimab/imdevimab, have recently been approved by the FDA for emergency use authorization to avoid hospitalization in patients who are at a higher risk for developing severe symptoms of COVID-19.